Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Canada to approve DSM biofungicide

The Canadian Pest Management Regulatory Agency (PMRA) has proposed the approval of Dutch nutritional products company DSM’s (Delft) biofungicide, Zivion M (natamycin), for the suppression of dry bubble disease ( Verticillium fungicola) of mushrooms. Natamycin is naturally produced by the soil bacterium, Streptomyces natalensis, and inactivates germinating fungal spores, the PMRA notes. It has a long history as a food additive and is approved as such in more than 70 countries, the Agency. The US EPA granted a tolerance exemption to DSM for natamycin this month. The Canadian registration decision is subject to a 45-day public comment from May 25th.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts